A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 16,943 shares of CSTL stock, worth $469,659. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,943
Previous 874,609 98.06%
Holding current value
$469,659
Previous $19 Million 97.46%
% of portfolio
0.01%
Previous 0.4%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.4 - $31.47 $14.9 Million - $27 Million
-857,666 Reduced 98.06%
16,943 $483,000
Q2 2024

Aug 14, 2024

SELL
$18.84 - $24.94 $1.01 Million - $1.33 Million
-53,408 Reduced 5.76%
874,609 $19 Million
Q1 2024

May 15, 2024

SELL
$18.06 - $25.3 $675,642 - $946,498
-37,411 Reduced 3.88%
928,017 $20.6 Million
Q4 2023

Feb 14, 2024

BUY
$12.19 - $22.43 $229,269 - $421,863
18,808 Added 1.99%
965,428 $20.8 Million
Q3 2023

Nov 14, 2023

BUY
$13.28 - $20.3 $12.6 Million - $19.2 Million
946,620 New
946,620 $16 Million
Q4 2022

Feb 14, 2023

BUY
$18.08 - $30.0 $4.92 Million - $8.16 Million
272,135 New
272,135 $6.41 Million
Q4 2019

Feb 14, 2020

SELL
$15.74 - $35.04 $1.46 Million - $3.24 Million
-92,477 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$18.09 - $27.92 $1.67 Million - $2.58 Million
92,477 New
92,477 $1.67 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $729M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.